By Josh Beckerman
Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units.
The 52-week high of $5.94 took place on Aug. 12.
Each unit consists of a Series H convertible preferred share and a warrant to buy half of a preferred share.
Biolase said May 4 that it planned to offer units. The next day, shares declined 25%, to 20 cents.
Write to Josh Beckerman at josh.beckerman@wsj.com